CXCR3/CXCR3 Ligand Biological Axis Impairs RENCA Tumor Growth by a Mechanism of Immunoangiostasis

Journal of Immunology - United States
doi 10.4049/jimmunol.176.3.1456
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Unlocking Tumor Vascular Barriers With CXCR3: Implications for Cancer Immunotherapy

OncoImmunology
OncologyAllergyImmunology
2016English

CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2016English

Chemokine Receptor CXCR3 Expression in Inflammatory Bowel Disease

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2001English

095 Targeting CXCR3 in a Mouse Model of Cutaneous Lupus Eeythematosus

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Salmonella Persist in Activated Macrophages in T Cell-Sparse Granulomas but Are Contained by Surrounding CXCR3 Ligand-Positioned Th1 Cells

Immunity
Infectious DiseasesAllergyImmunology
2018English

Fas Ligand Is Responsible for CXCR3 Chemokine Induction in CD4+ T Cell-Dependent Liver Damage

Journal of Immunology
AllergyImmunology
2006English

CXCR3 (Chemokine (C-X-C Motif) Receptor 3)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

CXCR3 and IFN Protein-10 in Pneumocystis Pneumonia

Journal of Immunology
AllergyImmunology
2006English

IL-4 Enhances Keratinocyte Expression of CXCR3 Agonistic Chemokines

Journal of Immunology
AllergyImmunology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy